Listed
SME IPO
NSE
88
IPO Health Score™
★★★★★ Strong Apply
Avience Biomedicals
Symbol: AVIENCE
Grey Market Premium (GMP)
GMP ACTIVE
Latest GMP Value
+₹70.00
Updated: Recent
Estimated Listing Price
₹70.00
Based on Max Price: ₹0
Estimated Listing Gain
+0.00%
Projections only
IPO Lifecycle Tracker
Completed stages are highlighted in green
10-Stage Interactive IPO Journey
✓
1. DRHP
✓
2. SEBI
✓
3. Anchor
✓
4. Opens
5
5. Live Bidding
6
6. Closes
7
7. Allotment
8
8. Refund
9
9. Demat
10
10. Listing
IPO Quick Highlights
Price Band
N/A
Lot Size
N/A
Min. Investment
N/A
Market Capitalization
₹167.95 Cr.
Issue Size
N/A
Listing Price
₹395.20
(+90.00%)
IPO Timeline
- IPO Opens 18 Jun 2026
- IPO Closes 22 Jun 2026
- Allotment Date 23 Jun 2026
- Listing Date 24 Jun 2026
About the Company
Company description is currently unavailable for this IPO.
Financial Performance
Values in ₹ Crores| Key Metric | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 10.15 | 10.92 | 23.96 | 45.24 | Growth |
| Profit After Tax (PAT) | 0.71 | 0.78 | 2.14 | 7.23 | Growth |
| Operating Margin (%) | 12.51% | 13.19% | 18.20% | 26.53% | Up |
| Total Assets | 6.09 | 10.01 | 34.65 | 56.52 | - |
| Net Worth | 2.79 | 4.07 | 6.21 | 22.78 | - |
| Borrowings (Debt) | 2.49 | 2.66 | 15.13 | 22.16 | - |
| Debt to Equity Ratio | 0.89 | 0.65 | 2.44 | 0.97 | - |
Sponsored
IPO Valuation
P/E Ratio
24.45
Price to Book (P/B)
7.76
Earnings Per Share (EPS)
₹13.18
Return on Equity (ROE)
N/A
Net Asset Value (NAV)
₹41.26
IPO Lot Size Details
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Minimum) | 1 Lot | 1 Shares | ₹0.00 |
Frequently Asked Questions
Avience Biomedicals operates in the its sector industry. The company is active in its primary sector and is launching an Initial Public Offering (IPO) to raise capital from public investors.
The price band of Avience Biomedicals IPO is set at ₹208.00 per share. Investors can bid within this price range during the IPO subscription window.
The minimum bid lot size for Avience Biomedicals IPO is 1 share(s). At the cap price of ₹208.00, the minimum investment required for a retail investor is approximately ₹208.
The subscription opens on June 18, 2026 and closes on June 22, 2026. During this period, eligible retail, HNI, and institutional buyers can place their bids via ASBA or UPI.
The tentative date for allotment is June 23, 2026, and the shares are expected to be listed on the exchanges on June 24, 2026. The shares will be listed on the NSE.
The current Grey Market Premium (GMP) is estimated at ₹70.00 per share. This indicates an estimated listing premium of approximately 33.65% over the issue price. Please note that GMP is unofficial and volatile, driven by market demand in the grey market.
You can apply for the Avience Biomedicals IPO online using ASBA through your bank account, or via UPI through broker apps like Groww, Zerodha, or Upstox. ASBA blocks funds in your account without debiting them until allotment.
You May Also Like • Sponsored
Other Active IPOs
Avience Biomedicals IPO Activity & News Timeline
Latest updates, regulatory filings, subscription activity & listing coverage
No specific news stories linked to Avience Biomedicals yet.
Our automated webjob synchronizes news hourly. Check back soon!